{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:42:06Z","timestamp":1780548126903,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","award":["10th Faculty Competition\", 2016, Radiology, Radio-oncology and Nuclear Medicine Department, Faculty of Medicine,"],"award-info":[{"award-number":["10th Faculty Competition\", 2016, Radiology, Radio-oncology and Nuclear Medicine Department, Faculty of Medicine,"]}],"id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00259-019-04302-x","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T12:48:35Z","timestamp":1552394915000},"page":"1309-1324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET\/CT) findings in children with encephalitis and comparison to conventional imaging"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7467-6562","authenticated-orcid":false,"given":"Sophie","family":"Turpin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Levasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"D\u00e9carie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Barsalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Decaluwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"4302_CR1","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3201\/eid2109.150295","volume":"21","author":"KC Bloch","year":"2015","unstructured":"Bloch KC, Glaser CA. Encephalitis surveillance through the emerging infections program, 1997-2010. Emerg Infect Dis. 2015;21:1562\u20137.","journal-title":"Emerg Infect Dis"},{"key":"4302_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1542\/pir.33-3-122","volume":"33","author":"SJ Falchek","year":"2012","unstructured":"Falchek SJ. Encephalitis in the pediatric population. Pediatr Rev. 2012;33:122\u201333.","journal-title":"Pediatr Rev"},{"key":"4302_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","volume":"30","author":"RC Dale","year":"2017","unstructured":"Dale RC, Gorma MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics and emerging challenges. Curr Opin Neurol. 2017;30:334\u201344.","journal-title":"Curr Opin Neurol"},{"key":"4302_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Celluci T, et al. A clinical approach for the diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"4302_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar B, et al. Case definitions, diagnosis algorithms and priorities: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114\u201328.","journal-title":"Clin Infect Dis"},{"key":"4302_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1086\/509330","volume":"43","author":"CA Glaser","year":"2006","unstructured":"Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies with encephalitis. Clin Infect Dis. 2006;43:1565\u201357.","journal-title":"Clin Infect Dis"},{"key":"4302_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11908-016-0545-6","volume":"18","author":"T He","year":"2016","unstructured":"He T, Kaplan S, Kamboj M, Tang YW. Laboratory diagnosis of central nervous system infection. Curr Infect Dis Rep. 2016;18:35\u201347.","journal-title":"Curr Infect Dis Rep"},{"key":"4302_CR8","volume-title":"Autoimmune encephalitis: history and current knowledge","author":"FE Sominer","year":"2016","unstructured":"Sominer FE. Autoimmune encephalitis: history and current knowledge. Copenhagen: Statens Serum Institut; 2016. Version 5.8."},{"key":"4302_CR9","doi-asserted-by":"crossref","unstructured":"Morbelli S, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, et al. On behalf of the EANM and SNMMI. The need for standardization and of large clinical studies in an emerging indication of 18F- FDG: the auto-immune encephalitis. Eur J Nucl Med Mol Imaging. 2017;44:353\u20137.","DOI":"10.1007\/s00259-016-3589-9"},{"key":"4302_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2967\/jnumed.117.201889","volume":"59","author":"S Turpin","year":"2018","unstructured":"Turpin S, Martineau PJ, Levasseur MA, Lambert R. Modeling the effects of age and gender on normal pediatric brain metabolism using 18F-FDG PET\/CT. J Nucl Med. 2018;59:1118\u201324.","journal-title":"J Nucl Med"},{"key":"4302_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00415-012-6657-5","volume":"260","author":"N Melzer","year":"2013","unstructured":"Melzer N, Meuth SG, Wiendl H. Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol. 2013;260:1215\u201333.","journal-title":"J Neurol"},{"key":"4302_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune disease of the central nervous system. Physiol Rev. 2017;97:839\u201387.","journal-title":"Physiol Rev"},{"key":"4302_CR13","doi-asserted-by":"crossref","unstructured":"Pignolet BSL, Gebauer CMT, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies. A beneficial antitumor immune response going awry. OncoImmunology. 2013;2:e27384. (1\u201310).","DOI":"10.4161\/onci.27384"},{"key":"4302_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/cid\/cir1038","volume":"54","author":"MS Gable","year":"2012","unstructured":"Gable MS, Sherriff H, Dalmau J, Tilleu DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54:899\u2013904.","journal-title":"Clin Infect Dis"},{"key":"4302_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40734-017-0056-0","volume":"4","author":"DJ Erlich","year":"2017","unstructured":"Erlich DJ, Walker EH. Functional neuroimaging and chorea: a systematic review. J Clin Mov Disord. 2017;4:8\u201327.","journal-title":"J Clin Mov Disord"},{"key":"4302_CR16","doi-asserted-by":"crossref","unstructured":"Delle AcqueGiogio SM, Caprio MG, Galante F, Russo G, Romano A, Vergara E, et al. Clinical value of perfusion abnormalities of brain on Technitium-9m HMPAO single photon emission computed tomography in children with Sydenham chorea. J Child Neurol. 2017;32:316\u201321.","DOI":"10.1177\/0883073816681258"},{"key":"4302_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/RLU.0b013e318192c435","volume":"34","author":"L Ho","year":"2009","unstructured":"Ho L. Hypermetabolism in bilateral basal ganglia in Sydenham chorea on 18F-FDG PET\/CT. Clin Nucl Med. 2009;34:114\u20136.","journal-title":"Clin Nucl Med"},{"key":"4302_CR18","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","volume":"260","author":"A Baumgartner","year":"2013","unstructured":"Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013;260:2744\u201353.","journal-title":"J Neurol"},{"key":"4302_CR19","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","volume":"58","author":"LB Solnes","year":"2017","unstructured":"Solnes LB, Jones KM, Rowe SP, Pattanayak P, Nalluri A, Venkatesan A, et al. Diagnostic value of 18F-FDG PET\/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. J Nucl Med. 2017;58:1307\u201313.","journal-title":"J Nucl Med"},{"key":"4302_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00234-017-1956-2","volume":"60","author":"M Tripathi","year":"2018","unstructured":"Tripathi M, Tripathi M, Roy SG, Parida GK, Ihtisham K, Dash D, et al. Metabolic topography of autoimmune non-paraneoplastic encephalitis. Neuroradiology. 2018;60:189\u201398.","journal-title":"Neuroradiology"},{"key":"4302_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.braindev.2015.10.013","volume":"38","author":"S Lagarde","year":"2016","unstructured":"Lagarde S, Lepine A, Caietta E, Pelletier F, Boucrot J, Chabrol B, et al. Cerebral 18 FluoroDeoxyglucose positron emission tomography in paediatric anti N-Metyl-D-aspartate receptor encephalitis: a case series. Brain and Development. 2016;38:461\u201370.","journal-title":"Brain and Development"},{"key":"4302_CR22","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1212\/NXI.0000000000000413","volume":"5","author":"JC Probasco","year":"2018","unstructured":"Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, et al. Decreased occipital lobe metabolism by FDG PET\/CT: an anti-NMDA receptor encephalitis biomarker. Neurol Neuroimmunol Neuroinflamm. 2018;5:e413\u20139.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4302_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","volume":"83","author":"F Leypoldt","year":"2012","unstructured":"Leypoldt F, Buchert R, Kleiter I, Mariehagen J, Gelderblom M, Magnus T, et al. Fluorodeoxyglucose positron emission tomography in anti-Nmethyl-D-aspartate receptor encephalitis; distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012;83:681\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4302_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RLU.0000000000000998","volume":"41","author":"J Yuan","year":"2016","unstructured":"Yuan J, Guan H, Zhou X, Niu N, Li F, Cui L, et al. Changing brain metabolism patterns in subjects with ANMDARE: serial 18F-FDG PET\/CT findings. Clin Nucl Med. 2016;41:1\u20135.","journal-title":"Clin Nucl Med"},{"key":"4302_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2010.04.019","volume":"43","author":"SC Pillai","year":"2010","unstructured":"Pillai SC, Gill D, Webster R, Howman-Giles R, Dale RC. Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol. 2010;43:218\u201320.","journal-title":"Pediatr Neurol"},{"key":"4302_CR26","doi-asserted-by":"publisher","unstructured":"Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, et al. Abnormal brain metabolism on FDG-PET\/CTis a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2017;4:e352. (1\u201310). \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000352\n                    \n                  .","DOI":"10.1212\/NXI.0000000000000352"},{"key":"4302_CR27","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00259-008-0826-x","volume":"35","author":"J Strauss","year":"2008","unstructured":"Strauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, et al. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008;35:1581\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4302_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/ard.59.5.377","volume":"59","author":"SM Weiner","year":"2000","unstructured":"Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of 18F-Fluorodeoxyglucose PET. Ann Rheum Dis. 2000;59:377\u201385.","journal-title":"Ann Rheum Dis"},{"key":"4302_CR29","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/0961203312459104","volume":"21","author":"SW Lee","year":"2012","unstructured":"Lee SW, Park MC, Lee SK, Park YB. The efficacy of brain 18F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus subjects with normal brain magnetic resonance imaging findings. Lupus. 2012;21:1531\u20137.","journal-title":"Lupus"},{"key":"4302_CR30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/art.20150","volume":"50","author":"M Nowak","year":"2004","unstructured":"Nowak M, Carrasquillo JA, Yarboro CH, Bacharach SL, Whatley M, et al. A pilot study of the use of FDG PET to assess the distribution of activated lymphocytes in subjects with SLE. Arthritis Rheum. 2004;50:1233\u20138.","journal-title":"Arthritis Rheum"},{"key":"4302_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00415-013-7228-0","volume":"261","author":"E Pari","year":"2014","unstructured":"Pari E, Rinaldi F, Premi E, Codella M, Renata R, Paghera B, et al. A follow-up 18F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status-epileptic treated with plasmapheresis. J Neurol. 2014;261:663\u20137.","journal-title":"J Neurol"},{"key":"4302_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1176\/ajp.151.5.681","volume":"151","author":"EJ Bartlett","year":"1994","unstructured":"Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, et al. Effects of haloperidol challenge in regional glucose utilization in normal human subjects. Am J Psychiatry. 1994;151:681\u20138.","journal-title":"Am J Psychiatry"},{"key":"4302_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0925-4927(98)00002-X","volume":"82","author":"GJ Wang","year":"1998","unstructured":"Wang GJ, Volkow ND, Fowler JS, Hitzemann RJ, Pappas NR, Netuzil N. Evaluation of gender differences in regional brain metabolic responses to lorazepam. Psychiatry Res (Neuro). 1998;82:37\u201347.","journal-title":"Psychiatry Res (Neuro)"},{"key":"4302_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bja.2018.04.008","volume":"121","author":"L Laaksonen","year":"2018","unstructured":"Laaksonen L, Kallioinene M, L\u00e5ngsj\u00f6 J, Laitio T, Scheinin A, Scheinin J, et al. Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on the regional cerebral glucose metabolism in humans: a positron emission tomography study. Br J Anaesth. 2018;121:281\u201390.","journal-title":"Br J Anaesth"},{"key":"4302_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2967\/jnumed.116.187492","volume":"58","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Feng J, Wu S, Hou H, Ji J, Zhang K, et al. Glucose metabolic profile by visual assessment combined with statistical parametric mapping analysis in pediatric patients with epilepsy. J Nucl Med. 2017;58:1293\u20139.","journal-title":"J Nucl Med"},{"key":"4302_CR36","doi-asserted-by":"crossref","unstructured":"De Blasi B, Barnes A, Galazzo IB, Hua CH, Shulkin B, Koepp M, et al. Age-specific 18F-FDG image processing pipelines and analysis are essential for individual mapping of seizure foci in paediatric patient with intractable epilepsy. J Nucl Med. 2018;59:1590\u20136.","DOI":"10.2967\/jnumed.117.203950"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04302-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04302-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04302-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:20:11Z","timestamp":1583871611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04302-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4302"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04302-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the ethical committee of our institution.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}